Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease
NCT05643651
Aneurysm, Cardiovascular Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT Number: NCT06305611
Kawasaki disease (KD) is currently the leading cause of acquired heart diseases in children in developed countries. Cardiac involvement is the main determinant of the long-term prognosis of these patients, as coronary aneurisms (CAAs) may lead to ischemic heart disease and even sudden death. The current standard of care for KD has consistently reduced CAAs frequency from 25-30% to about 5%. Unfortunately, 10-20% of KD patients results resistant to standard treatment leading to a major risk of cardiac complications. Thus, scoring systems have been constructed in order to identify patients likely to be resistant to IVIG and who may benefit from more aggressive initial therapy. Different scoring scales developed by Kobayashi, Egami et Sano had shown a good sensitivity (77-86%) and specificity (67-86%) in predicting IVIG unresponsiveness in Japanese populations. However, their predictive value was not confirmed by subsequent studies in different ethnic populations. Recently, the French Kawanet group have proposed a IVIG unresponsiveness score that provided good sensitivity and acceptable specificity in a non-Asian KD population even if it was not subsequent validated by an external study. In our study population, the achievement of specificity and sensitivity values for both scores consistent with those reported by the original studies (sensitivity 70% and specificity 80% for Kobayashi and sensitivity 77% and specificity 60% for Kawanet), will be considered a success.
Interested in participating?
Request Info1 year–17 year
All sexes
Observational
Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: through study completion, an average of 1 year
IVIG resistance rate in patients with KD and stratification according to different ethnic groups.
Time frame: through study completion, an average of 1 year
percentage of IVIG-resistant patients who met the Kobayashi and KAWANET criteria, and specificity and sensitivity of the criteria within the different ethnic groups.
Contact information is provided by the study sponsor or research team.
Meyer Children's Hospital IRCCS
Other
Comparison and Performance of Kobayashi and Kawanet IVIg Resistance Scores in a Multi-centric European and North Indian Cohort of KaWasaki dIsease (the KIWI Study)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05643651
Aneurysm, Cardiovascular Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT07530640
Cardiovascular Diseases, Coronary Artery Abnormalities
Shanghai, China
View Trial DetailsNCT07291245
Cardiovascular Diseases, Hemic and Lymphatic Diseases
San Diego, California, United States
View Trial DetailsNCT06978439
Aneurysm, Cardiovascular Diseases
Shanghai, Shanghai Municipality, China
View Trial Details